Blockade

Blockade describes any mechanism by which a molecule prevents a receptor, ion channel, or transporter from performing its normal function. The blocking molecule typically occupies the binding site without activating it — an action called antagonism — or physically obstructs an ion channel pore. Either way, the downstream signal that would normally follow is suppressed.

The term covers a spectrum of mechanisms. Competitive blockers can be displaced when enough natural signal molecules are present; non-competitive blockers bind so tightly, or to a different site, that the block holds regardless. What unites them is the outcome: a target that is occupied but silent.

How it works · its role

In competitive blockade, the blocking molecule and the body's own neurotransmitter compete for the same binding site. At low blocker concentrations the natural signal can still break through; at higher concentrations the block dominates. This reversibility makes competitive antagonists useful as antidotes — they can be displaced when circumstances change.

Ion channel blockade works differently. Some molecules lodge inside the channel pore after it opens, plugging it from within. The block is use-dependent: the more the channel activates, the more blocker enters, producing suppression that deepens under repeated stimulation.

Transporter blockade prevents a recycling protein from clearing neurotransmitters back into the releasing neuron. The neurotransmitter accumulates and its effect is prolonged. Unlike receptor blockade, which suppresses signalling, transporter blockade amplifies it — the same signal persists longer than it otherwise would.

Relevance to substances & effects

Dissociative substances such as ketamine, PCP, and dextromethorphan act through use-dependent blockade of the NMDA channel. This prevents calcium from crossing the synapse and produces pain suppression, perceptual distortion, and the disconnected state characteristic of the class. The block is graded: at lower concentrations it is partial; at higher doses it approaches full disconnection.

Stimulants including cocaine and amphetamines block monoamine transporters — dopamine, norepinephrine, and serotonin — raising synaptic levels of each. SSRIs apply a more selective blockade at the serotonin transporter, producing gradual mood changes over weeks rather than the immediate effects of a stimulant.

Opioid antagonists such as naloxone and naltrexone competitively block opioid receptors. Because the block is reversible, a sufficient opioid dose can displace them — which is why repeat naloxone doses are sometimes needed in high-potency overdoses. Atypical antipsychotics typically combine dopamine D2 and serotonin 5-HT₂A blockade, a dual mechanism that shapes both their therapeutic effects and their side-effect profile.